Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcadia Biosciences (RKDA) Assets Average (2016 - 2025)

Arcadia Biosciences' Assets Average history spans 11 years, with the latest figure at $7.6 million for Q4 2025.

  • For Q4 2025, Assets Average fell 47.39% year-over-year to $7.6 million; the TTM value through Dec 2025 reached $7.6 million, down 47.39%, while the annual FY2025 figure was $10.0 million, 39.61% down from the prior year.
  • Assets Average reached $7.6 million in Q4 2025 per RKDA's latest filing, down from $8.2 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $70.8 million in Q2 2021 to a low of $7.6 million in Q4 2025.
  • Average Assets Average over 5 years is $30.0 million, with a median of $26.9 million recorded in 2023.
  • Peak YoY movement for Assets Average: surged 102.21% in 2021, then tumbled 49.79% in 2025.
  • A 5-year view of Assets Average shows it stood at $51.6 million in 2021, then crashed by 38.54% to $31.7 million in 2022, then tumbled by 31.9% to $21.6 million in 2023, then crashed by 33.39% to $14.4 million in 2024, then plummeted by 47.39% to $7.6 million in 2025.
  • Per Business Quant, the three most recent readings for RKDA's Assets Average are $7.6 million (Q4 2025), $8.2 million (Q3 2025), and $10.4 million (Q2 2025).